Pathophysiology and Characterisation of NAFLD

NAFLD 的病理生理学和特征

基本信息

  • 批准号:
    7391610
  • 负责人:
  • 金额:
    $ 29.41万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-04-01 至 2010-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Non-alcoholic fatty liver disease (NAFLD) is the most common form of liver disease in the United States. The high prevalence of NAFLD is largely on the basis of relentless increases in the prevalences of obesity and insulin resistance. The basis of progressive histological injury in a proportion of patients with NAFLD is poorly understood. The overall goals of this project are to 1) develop a model to identify patients with more histologically severe grades of NAFLD and 2) better define the pathophysiological basis of histological progression of NAFLD. Two hypotheses and specific aims have been developed to achieve these goals. Our first hypothesis is that indices of insulin sensitivity, hyperinsulinemia and/or subclinical inflammation can be used to generate a model capable of identifying patients at increased risk for more histologically severe grades of NAFLD. The first specific aim is to prospectively screen a panel of biological parameters for their ability to identify patients at risk for histologically severe NAFLD, as measured by NAFLD grade. In a pilot study of patients with varying degrees of severity of NAFLD, we found that more histologically severe NAFLD is independently associated with greater percent body fat, higher C-reactive protein and fasting insulin levels. Strong trends for an association with severity of NAFLD grade were also seen for higher IGFBP-1 levels, % truncal fat, HGH levels, and continuous glucose monitoring profiles. We now propose to carry out detailed assessments of these and other markers of subclinical inflammation, insulin sensitivity, insulin-like growth factor axis and assessments of anthropometry in patients with grades 1-3 of NAFLD and in controls. Our second hypothesis is that the inflammation and progressive fibrosis that can occur in NAFLD are substantially due to increased oxidative stress. The second specific aim is to determine the mechanism and effects of increased oxidative stress in NAFLD. Oxidative stress is thought to be central to hepatocellular injury in NAFLD. Our preliminary data demonstrate a possible pre-transcriptional basis of increased oxidative stress in patients with more histologically progressive NASH. In a logical extension of these experiments, we now propose to use high-throughput mass spectrometry analysis, using an ICAT tagging technique, to measure differential hepatic protein abundance, including of peroxisomal proteins, in patients with NAFLD grades 1-3, and also in controls. We believe that these experiments will generate mechanistic insight into the cause and effects of increased oxidative stress in patients with histologically progressive NAFLD.
描述(由申请人提供):非酒精性脂肪性肝病(NAFLD)是美国最常见的肝病形式。NAFLD的高患病率在很大程度上是基于肥胖和胰岛素抵抗患病率的持续增加。对一部分NAFLD患者进行性组织学损伤的基础知之甚少。该项目的总体目标是:1)开发一种模型,以识别组织学上更严重的NAFLD患者; 2)更好地定义NAFLD组织学进展的病理生理学基础。为实现这些目标,提出了两个假设和具体目标。我们的第一个假设是,胰岛素敏感性、高胰岛素血症和/或亚临床炎症的指数可用于生成能够识别组织学上更严重等级的NAFLD风险增加的患者的模型。第一个具体目标是前瞻性地筛选一组生物参数,以确定组织学上严重NAFLD风险的患者的能力,如通过NAFLD等级测量的。在一项针对不同严重程度NAFLD患者的初步研究中,我们发现组织学上更严重的NAFLD与更高的体脂百分比、更高的C反应蛋白和空腹胰岛素水平独立相关。IGFBP-1水平、躯干脂肪百分比、HGH水平和连续血糖监测曲线升高也与NAFLD严重程度相关。我们现在建议对这些和其他亚临床炎症标志物、胰岛素敏感性、胰岛素样生长因子轴进行详细评估,并对1-3级NAFLD患者和对照组进行人体测量评估。我们的第二个假设是,NAFLD中可能发生的炎症和进行性纤维化主要是由于氧化应激增加。第二个具体目标是确定NAFLD中氧化应激增加的机制和影响。氧化应激被认为是NAFLD肝细胞损伤的核心。我们的初步数据表明,在组织学进展性NASH患者中,氧化应激增加可能是转录前基础。在这些实验的逻辑延伸中,我们现在建议使用高通量质谱分析,使用ICAT标记技术,来测量NAFLD 1-3级患者和对照组的差异肝蛋白丰度,包括过氧化物酶体蛋白。我们相信,这些实验将产生机制洞察的原因和影响增加氧化应激患者组织学进展NAFLD。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL R CHARLTON其他文献

MICHAEL R CHARLTON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL R CHARLTON', 18)}}的其他基金

Pathophysiology and Characterisation of NAFLD
NAFLD 的病理生理学和特征
  • 批准号:
    7591261
  • 财政年份:
    2005
  • 资助金额:
    $ 29.41万
  • 项目类别:
Pathophysiology and Characterisation of NAFLD
NAFLD 的病理生理学和特征
  • 批准号:
    7035248
  • 财政年份:
    2005
  • 资助金额:
    $ 29.41万
  • 项目类别:
Pathophysiology and Characterisation of NAFLD
NAFLD 的病理生理学和特征
  • 批准号:
    7211326
  • 财政年份:
    2005
  • 资助金额:
    $ 29.41万
  • 项目类别:
Pathophysiology and Characterisation of NAFLD
NAFLD 的病理生理学和特征
  • 批准号:
    6859186
  • 财政年份:
    2005
  • 资助金额:
    $ 29.41万
  • 项目类别:
REDUCTION OF HCV RECURRANCE AFTER LIVER TRANSPLANTATION
减少肝移植后 HCV 复发
  • 批准号:
    2718450
  • 财政年份:
    1998
  • 资助金额:
    $ 29.41万
  • 项目类别:
THE ROLE GLUCAGON IN THE DISPOSAL OF AMINO ACIDS DURING AN AMINO ACID INFUSION
胰高血糖素在氨基酸输注过程中处理氨基酸的作用
  • 批准号:
    3763820
  • 财政年份:
  • 资助金额:
    $ 29.41万
  • 项目类别:
THE ROLE GLUCAGON IN THE DISPOSAL OF AMINO ACIDS DURING AN AMINO ACID INFUSION
胰高血糖素在氨基酸输注过程中处理氨基酸的作用
  • 批准号:
    3785879
  • 财政年份:
  • 资助金额:
    $ 29.41万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 29.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 29.41万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 29.41万
  • 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 29.41万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 29.41万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 29.41万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 29.41万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 29.41万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 29.41万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 29.41万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了